Source:http://linkedlifedata.com/resource/pubmed/id/16077967
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0015576,
umls-concept:C0033684,
umls-concept:C0085862,
umls-concept:C0162638,
umls-concept:C0205263,
umls-concept:C0246769,
umls-concept:C0334227,
umls-concept:C0376515,
umls-concept:C0597217,
umls-concept:C0740457,
umls-concept:C0752312,
umls-concept:C1120135,
umls-concept:C1299583,
umls-concept:C1370600,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1709059
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-8-3
|
pubmed:abstractText |
Protein phosphatases have been classified into two basic types, namely protein serine/threonine phosphatase (PP), and protein tyrosine phosphatase (PTP). Cpd 5 is a selective inhibitor of cdc25 phosphatases, which belong to members of PTPs and regulate cell proliferation by controlling cyclin-dependent kinases (cdks). The present study was undertaken to investigate the potential utility of Cpd 5 as an anti-neoplastic agent for renal cell carcinomas (RCCs). Three renal cancer cell lines, 769P, Sw839, and A498 were used. The effects of Cpd 5 on the viability of renal cancer cell lines was analyzed using an Alamar Blue assay. Apoptosis was determined by flow cytometric TUNEL analysis. Changes in the expression of cdc25 phosphatases, mitogen-activated protein kinases (MAPKs), and bcl-2 family proteins were detected using Western blot analysis. The apoptosis-inducing effect of Cpd 5 on human RCC tissue was analyzed through TUNEL staining of organ cultures from RCCs. Cpd 5 showed a strong cytotoxicity against all renal cancer cell lines with an apoptosis-inducing effect. All cell lines treated with Cpd 5 resulted in a down-regulation of cdc25A, cdc25B, and cdc25C, however, the MAPK pathways were not affected. In addition, the up-regulation of bax, and the down-regulation of bcl-2 and bcl-xL, was observed. In organ cultures from RCCs, TUNEL-positive apoptotic nuclei were observed when treated with Cpd 5. Cpd 5 was thus found to effectively inhibit the proliferation of human renal cancer cells while also inducing apoptosis by inhibiting cdc25 phosphatases and modulating bcl-2 family proteins. The administration of Cpd 5 may thus be an effective therapeutic approach for RCCs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-(2-hydroxyethylsulfanyl)-3-methyl-...,
http://linkedlifedata.com/resource/pubmed/chemical/BAX protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/BCL2L1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Vitamin K,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/cdc25 Phosphatases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1021-335X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
639-44
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16077967-Apoptosis,
pubmed-meshheading:16077967-Blotting, Western,
pubmed-meshheading:16077967-Cell Line, Tumor,
pubmed-meshheading:16077967-Cell Survival,
pubmed-meshheading:16077967-Dose-Response Relationship, Drug,
pubmed-meshheading:16077967-Enzyme Activation,
pubmed-meshheading:16077967-Flow Cytometry,
pubmed-meshheading:16077967-Humans,
pubmed-meshheading:16077967-In Situ Nick-End Labeling,
pubmed-meshheading:16077967-Kidney Neoplasms,
pubmed-meshheading:16077967-Mitogen-Activated Protein Kinases,
pubmed-meshheading:16077967-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:16077967-Vitamin K,
pubmed-meshheading:16077967-bcl-2-Associated X Protein,
pubmed-meshheading:16077967-bcl-X Protein,
pubmed-meshheading:16077967-cdc25 Phosphatases
|
pubmed:year |
2005
|
pubmed:articleTitle |
Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells.
|
pubmed:affiliation |
Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|